A Phase III, Open-Label Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters

Trial Profile

A Phase III, Open-Label Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jan 2017

At a glance

  • Drugs Tenecteplase (Primary)
  • Indications Catheter thrombosis
  • Focus Therapeutic Use
  • Acronyms TROPICS-4
  • Sponsors Genentech
  • Most Recent Events

    • 24 Dec 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top